NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Biz Daily Online

Global stocks, oil slip after Fed points to more rate hikes

Nov 14, 2018

BEIJING — Global stocks and the price of oil fell Friday after the U.S. Federal Reserve suggested it will keep raising interest rates, tightening the supply of money that has supported markets in recent years. KEEPING SCORE: Germany's DAX lost 0.7 percent to 11,442 and France's CAC 40 lost 1.1 percent to 5,077. London's FTSE shed 0.9 percent to 7,076. On Wall Street, the future for the Standard & Poor's 500 index was off 0.6 percent and that for the Dow Jones Industrial Average declined 0.5 percent. ASIA'S DAY: The Shanghai Composite Index lost 1.4 percent to 2,598.87 and Tokyo's...

Global shares mixed after Wall Street tumble

Nov 14, 2018

BEIJING — Global stock prices were mixed Monday after Wall Street extended its slide, fueling concern about the global market outlook. KEEPING SCORE: In early trading, London's FTSE 100 rose 0.9 percent to 6,999.72 and Germany's DAX gained 0.4 percent to 11,253.50. France's CAC 40 advanced 0.3 percent to 4,980.45. On Friday, the CAC 40 dropped 1.3 percent and the DAX and FTSE 100 both slide 0.9 percent. On Wall Street, futures for the Standard & Poor's 500 index and the Dow Jones Industrial Average were off 0.1 percent. ASIA'S DAY: The Shanghai Composite Index lost 2.2 percent to 2,542.10...

European shares mixed after sharp drops in Asia, US

Nov 14, 2018

BANGKOK — Stock prices were mixed Thursday in early European trading as markets settled somewhat after steep declines in Asia and the U.S. spurred by worries over trade and the U.S. economy. Futures for the Dow Jones Industrial Average and the Standard & Poor's 500 were higher, suggesting a likely revival of buying sentiment. Britain's FTSE 100 lost 0.3 percent to 6,943.14 while Germany's DAX added 0.1 percent to 11,198.04 and the CAC 40 in France climbed 0.7 percent to 4,987.78. It was unclear if the gains were a return to calm or only a respite from the torrent of...

Share sell-off moderates in Asia after rout on Wall Street

Nov 14, 2018

BANGKOK — Shares fell moderately in Asia on Thursday after another torrent of selling on Wall Street sent the Dow Jones Industrial Average plummeting more than 600 points, erasing its gains for the year. Japan's Nikkei 225 index sank sharply on the open but leveled off, regaining some lost ground. By mid-morning it was down 2.9 percent at 21,443.72. The Shanghai Composite index slipped 1.6 percent to 2,561.36 and Hong Kong's Hang Seng index skidded 1.8 percent to 24,785.68. Charts for the entire region were awash with the red that indicates losses, but the declines were mostly in the 2...

Asian stocks tumble after Wall Street skids, China slows

Nov 14, 2018

BEIJING — Asian stock markets sank Friday after Wall Street declined on losses for tech and industrial stocks and Chinese economic growth slowed. KEEPING SCORE: Tokyo's Nikkei 225 index fell 1.1 percent to 22,411.33 and Seoul's Kospi shed 0.3 percent to 2,141.06. The Shanghai Composite Index was flat at 2,485.99 and Hong Kong's Hang Seng fell 0.3 percent to 25,378.50. Sydney's S&P-ASX 200 shed 0.2 percent to 5,929.50 and benchmarks in New Zealand, Taiwan and Southeast Asia also retreated. WALL STREET: Investors sold technology and internet stocks, industrials, and companies that rely on consumer spending amid worries about economic growth....

About Us

Biz Daily Online gives a complete understanding of the world of business to you. Get today’s business news and learn about the trends that are affecting every business here.

Contact us: sales[at]bizdailyonline.com

Subscribe Now!